Positron Emission Tomography has become increasingly relevant in clinical practice for diagnostic purposes. A major concern regarding radiopharmaceuticals in general is how quality requirements can be guaranteed in nuclear medicine departments or in cases where marketing authorization has been granted. This article focuses on issues related to the small-volume preparation of radiopharmaceuticals by a Research Institute after Good Manufacturing Practice implementation.

Implementation of Good Manufacturing Practice in small-volume production of [18F]FDG: a case report of performance measurements

D Petroni;M Poli;L Menichetti
2012

Abstract

Positron Emission Tomography has become increasingly relevant in clinical practice for diagnostic purposes. A major concern regarding radiopharmaceuticals in general is how quality requirements can be guaranteed in nuclear medicine departments or in cases where marketing authorization has been granted. This article focuses on issues related to the small-volume preparation of radiopharmaceuticals by a Research Institute after Good Manufacturing Practice implementation.
2012
Good Manufacturing Practice (GMP)
Positron Emission Tomography (PET)
Radiopharmaceuticals
[18F
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/211166
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact